Mikhak Zamaneh 4
4 · TFF Pharmaceuticals, Inc. · Filed Jul 8, 2024
Insider Transaction Report
Form 4
Mikhak Zamaneh
Chief Medical Officer
Transactions
- Award
Common Stock
2024-07-03+10,184→ 145,184 total - Award
Stock Options (Right to Buy)
2024-07-03+10,184→ 10,184 totalExercise: $1.82From: 2025-06-19Exp: 2034-07-03→ Common stock (10,184 underlying)
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff.
- [F2]One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.